PREDICT: A checklist for preventing preanalytical diagnostic errors in clinical trials

Clinical Chemistry and Laboratory Medicine

Volumn 58, Issue 4, 2020, Pages 518-526

  Lippi, Giuseppe ^a   Von Meyer, Alexander ^b   Cadamuro, Janne ^c   Simundic, Ana Maria ^d  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b Kliniken Nordoberpfalz AG   (Germany)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d Croatian Academy of Medical Sciences   (Croatia)

Author keywords

clinical trials; errors; laboratory medicine; preanalytical variability; studies

Indexed keywords

ADULT; CHECKLIST; CLINICAL CHEMISTRY; CLINICAL TRIAL (TOPIC); DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INFORMATION RETRIEVAL; PRE-ANALYTICAL PHASE; REVIEW; STANDARDIZATION; BLOOD SAMPLING; LABORATORY TECHNIQUE; PREVENTION AND CONTROL; PROCEDURES;

BLOOD SPECIMEN COLLECTION; CHECKLIST; CLINICAL LABORATORY TECHNIQUES; CLINICAL TRIALS AS TOPIC; DIAGNOSTIC ERRORS; HUMANS; PRE-ANALYTICAL PHASE;

EID: 85075921016     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2019-1089     Document Type: Article

References (62)

1. Lippi G, Guidi GC, Plebani M. One hundred years of laboratory testing and patient safety. Clin Chem Lab Med 2007;45:797-8. 17579534
2. Lippi G, Plebani M. A Six-Sigma approach for comparing diagnostic errors in healthcare-where does laboratory medicine stand? Ann Transl Med 2018;6:180. 10.21037/atm.2018.04.02 29951502
3. Lippi G, Betsou F, Cadamuro J, Cornes M, Fleischhacker M, Fruekilde P, et al. Preanalytical challenges-time for solutions. Clin Chem Lab Med 2019;57:974-81. 10.1515/cclm-2018-1334 30710481
4. Padoan A, Sciacovelli L, Zhou R, Plebani M. Extra-analytical sources of uncertainty: which ones really matter? Clin Chem Lab Med 2019;57:1488-93. 10.1515/cclm-2019-0197 31120858
5. Plebani M, Aita A, Padoan A, Sciacovelli L. Decision support and patient safety. Clin Lab Med 2019;39:231-44. 31036277 10.1016/j.cll.2019.01.003
6. Schiff GD, Hasan O, Kim S, Abrams R, Cosby K, Lambert BL, et al. Diagnostic error in medicine: analysis of 583 physician-reported errors. Arch Intern Med 2009;169:1881-7. 10.1001/archinternmed.2009.333 19901140
7. Lippi G, Bonelli P, Cervellin G. Prevalence and cost of hemolyzed samples in a large urban emergency department. Int J Lab Hematol 2014;36:e24-6. 10.1111/ijlh.12135
8. Cadamuro J, Fiedler GM, Mrazek C, Felder TK, Oberkofler H, Kipman U, et al. In-vitro hemolysis and its financial impact using different blood collection systems. J Lab Med 2016;40:49-55.
9. Simundic AM, Lippi G. Preanalytical phase-a continuous challenge for laboratory professionals. Biochem Med (Zagreb) 2012;22:145-9. 22838180
10. Lippi G, von Meyer A, Cadamuro J, Simundic AM. Blood sample quality. Diagnosis (Berl) 2019;6:25-31. 29794250
11. Banfi G, Lippi G. The impact of preanalytical variability in clinical trials: are we underestimating the issue? Ann Transl Med 2016;4:59. 26904581
12. Lippi G. The irreplaceable value of laboratory diagnostics: four recent tests that have revolutionized clinical practice. EJIFCC 2019;30:7-13. 30881270
13. Badrick T. Evidence-based laboratory medicine. Clin Biochem Rev 2013;34:43-6. 24151340
14. Lippi G, Simundic AM, Rodriguez-Manas L, Bossuyt P, Banfi G. Standardizing in vitro diagnostics tasks in clinical trials: a call for action. Ann Transl Med 2016;4:181. 10.21037/atm.2016.04.10
15. Simon R. Lost in translation: problems and pitfalls in translating laboratory observations to clinical utility. Eur J Cancer 2008;44:2707-13. 18977655 10.1016/j.ejca.2008.09.009
16. Hwang TJ, Carpenter D, Lauffenburger JC, Wang B, Franklin JM, Kesselheim AS. Failure of investigational drugs in late-stage clinical development and publication of trial results. JAMA Intern Med 2016;176:1826-33. 10.1001/jamainternmed.2016.6008 27723879
17. Morgan B, Hejdenberg J, Hinrichs-Krapels S, Armstrong D. Do feasibility studies contribute to, or avoid, waste in research? PLoS One 2018;13:e0195951. 29684043 10.1371/journal.pone.0195951
18. Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics 2019;20:273-86. 29394327 10.1093/biostatistics/kxx069
19. Cummings JL, Morstorf T, Zhong K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther 2014;6:37. 10.1186/alzrt269 25024750
20. Ioannidis JP, Bossuyt PM. Waste, leaks, and failures in the biomarker pipeline. Clin Chem 2017;63:963-72. 10.1373/clinchem.2016.254649 28270433
21. Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun 2018;11:156-64. 10.1016/j.conctc.2018.08.001 30112460
22. Crucitti T, Fransen K, Maharaj R, Tenywa T, Massinga Loembé M, Murugavel KG, et al. Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial. PLoS One 2010;5:e13592. 21048963 10.1371/journal.pone.0013592
23. Lippi G, Simundic AM. The preanalytical phase in the era of high-throughput genetic testing. What the future holds. Diagnosis (Berl) 2019;6:73-4. 30226211
24. Schultze AE, Irizarry AR. Recognizing and reducing analytical errors and sources of variation in clinical pathology data in safety assessment studies. Toxicol Pathol 2017;45:281-7. 28178899 10.1177/0192623316672945
25. Lippi G, Nybo M, Cadamuro J, Guimaraes JT, van Dongen-Lases E, Simundic AM. Blood glucose determination: effect of tube additives. Adv Clin Chem 2018;84:101-23. 29478513 10.1016/bs.acc.2017.12.003
26. Betsou F. Biospecimen processing method validation. Biopreserv Biobank 2015;13:69. 25880470 10.1089/bio.2015.1321
27. Ellervik C, Vaught J. Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin Chem 2015;61:914-34. 10.1373/clinchem.2014.228783 25979952
28. Gaignaux A, Ashton G, Coppola D, De Souza Y, De Wilde A, Eliason J, et al. A biospecimen proficiency testing program for biobank accreditation: four years of experience. Biopreserv Biobank 2016;14:429-39. 27195612 10.1089/bio.2015.0108
29. Stellino C, Hamot G, Bellora C, Trouet J, Betsou F. Preanalytical robustness of blood collection tubes with RNA stabilizers. Clin Chem Lab Med 2019;57:1522-9. 31112504 10.1515/cclm-2019-0170
30. Lehmann S, Guadagni F, Moore H, Ashton G, Barnes M, Benson E, et al. Standard preanalytical coding for biospecimens: review and implementation of the sample preanalytical code (SPREC). Biopreserv Biobank 2012;10:366-74. 10.1089/bio.2012.0012 24849886
31. Robb JA, Gulley ML, Fitzgibbons PL, Kennedy MF, Cosentino LM, Washington K, et al. A call to standardize preanalytic data elements for biospecimens. Arch Pathol Lab Med 2014;138:526-37. 10.5858/arpa.2013-0250-CP
32. Robb JA, Bry L, Sluss PM, Wagar EA, Kennedy MF, College of American Pathologists Diagnostic Information, et al. A call to standardize preanalytic data elements for biospecimens, part ii. Arch Pathol Lab Med 2015;139:1125-8. 10.5858/arpa.2014-0572-CP
33. International Organization for Standardization (ISO). Standard 20387:2018: biotechnology-biobanking-general requirements for biobanking. Geneva, Switzerland: International Organization for Standardization, 2018.
34. Moore HM, Kelly A, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality. Biopreserv Biobank 2011;9:57-70. 21826252 10.1089/bio.2010.0036
35. Vaught J, Abayomi A, Peakman T, Watson P, Matzke L, Moore H. Critical issues in international biobanking. Clin Chem 2014;60:1368-74. 25098414 10.1373/clinchem.2014.224469
36. Kellogg MD, Ellervik C, Morrow D, Hsing A, Stein E, Sethi AA. Preanalytical considerations in the design of clinical trials and epidemiological studies. Clin Chem 2015;61:797-803. 10.1373/clinchem.2014.226118 25901083
37. National Institutes of Health. Guidelines for good clinical laboratory practice standards. Bethesda, MD, USA: National Institutes of Health, 2019.
38. World Health Organization. Good Clinical Laboratory Practice (GCLP). Geneva, Switzerland: World Health Organization, 2009.
39. Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, Hitchcock R, et al. Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J Pharm Biomed Anal 2008;46:18-29. 18037599 10.1016/j.jpba.2007.10.010
40. Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009;8:113-7. 10.1021/pr800545q
41. Guest PC, Rahmoune H. Blood bio-sampling procedures for multiplex biomarkers studies. Methods Mol Biol 2017;1546:161-8. 27896765 10.1007/978-1-4939-6730-8_12
42. Lippi G, Plebani M, Guidi GC. The paradox in translational medicine. Clin Chem 2007;53:1553. 10.1373/clinchem.2007.087288 17644795
43. Lippi G, Bovo C, Ciaccio M. Inappropriateness in laboratory medicine: an elephant in the room? Ann Transl Med 2017;5:82. 10.21037/atm.2017.02.04 28275627
44. Cadamuro J, Ibarz M, Cornes M, Nybo M, Haschke-Becher E, von Meyer A, et al. Managing inappropriate utilization of laboratory resources. Diagnosis (Berl) 2019;6:5-13. 30096052
45. Kiechle FL, Arcenas RC, Rogers LC. Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in the clinical laboratory. Clin Chim Acta 2014;427:131-6. 23732401 10.1016/j.cca.2013.05.024
46. Kaul KL, Sabatini LM, Tsongalis GJ, Caliendo AM, Olsen RJ, Ashwood ER, et al. The case for laboratory developed procedures: quality and positive impact on patient care. Acad Pathol 2017;4:2374289517708309. 28815200
47. Morse JE, Calvert SB, Jurkowski C, Tassinari M, Sewell CA, Myers ER. Evidence-based pregnancy testing in clinical trials: recommendations from a multi-stakeholder development process. PLoS One 2018;13:e0202474. 30208049 10.1371/journal.pone.0202474
48. Montagnana M, Trenti T, Aloe R, Cervellin G, Lippi G. Human chorionic gonadotropin in pregnancy diagnostics. Clin Chim Acta 2011;412:1515-20. 10.1016/j.cca.2011.05.025 21635878
49. Lippi G, Sanchis-Gomar F. "Ultra-sensitive" cardiac troponins: requirements for effective implementation in clinical practice. Biochem Med (Zagreb) 2018;28:030501. 30429666 10.11613/BM.2018.030501
50. Association for Clinical Biochemistry and Laboratory Medicine. A statement from the ACB and LIMS manufacturers regarding CKD-EPI issued 09th February 2016. http://www.acb.org.uk/docs/default-source/documents/ckd-epi-statement-feb-2016-.pdf?sfvrsn=2. Last accessed, October 20, 2019.
51. Lippi G, Mattiuzzi C. The biomarker paradigm: between diagnostic efficiency and clinical efficacy. Pol Arch Med Wewn 2015;125:282-8. 25764446
52. Simundic AM, Bölenius K, Cadamuro J, Church S, Cornes MP, van Dongen-Lases EC, et al. Joint EFLM-COLABIOCLI Recommendation for venous blood sampling. Clin Chem Lab Med 2018;56:2015-38. 30004902 10.1515/cclm-2018-0602
53. Lippi G, Simundic AM. The EFLM strategy for harmonization of the preanalytical phase. Clin Chem Lab Med 2018;56:1660-6. 10.1515/cclm-2017-0277 28593910
54. Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M. Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chim Acta 2014;432:33-7. 10.1016/j.cca.2013.11.008
55. Kong FS, Zhao L, Wang L, Chen Y, Hu J, Fu X, et al. Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation. Transl Lung Cancer Res 2017;6:625-34. 10.21037/tlcr.2017.09.13
56. Cureau FV, Bloch KV, Henz A, Schaan CW, Klein CH, Oliveira CL, et al. Challenges for conducting blood collection and biochemical analysis in a large multicenter school-based study with adolescents: lessons from ERICA in Brazil. Cad Saude Publica 2017;33:e00122816.
57. Casson PR, Krawetz SA, Diamond MP, Zhang H, Legro RS, Schlaff WD, et al. Proactively establishing a biologic specimens repository for large clinical trials: an idea whose time has come. Syst Biol Reprod Med 2011;57:217-21. 21951166 10.3109/19396368.2011.604818
58. Marton MJ, Weiner R. Practical guidance for implementing predictive biomarkers into early phase clinical studies. Biomed Res Int 2013;2013:891391. 24236296
59. Favaloro EJ, Oliver S, Mohammed S, Ahuja M, Grzechnik E, Azimulla S, et al. Potential misdiagnosis of von Willebrand disease and haemophilia caused by ineffective mixing of thawed plasma. Haemophilia 2017;23:e436-43. 28750474 10.1111/hae.13305
60. Lippi G, Cadamuro J, von Meyer A, Simundic AM. Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med 2018;56:718-27. 10.1515/cclm-2017-1104 29373316
61. Simundic AM, Baird G, Cadamuro J, Costelloe SJ, Lippi G. Managing hemolyzed samples in clinical laboratories. Crit Rev Clin Lab Sci 2019:1-21. doi: 10.1080/10408363.2019.1664391. [Epub ahead of print]. 31603708
62. Lippi G, Salvagno GL, Mattiuzzi C. Public perception of diagnostic and laboratory errors among Internet users. Diagnosis (Berl) 2019;6:385-6. 30730835 10.1515/dx-2018-0103